Varga A, Nemeth I, Kemeny L, Varga J, Tiszlavicz L, Kumar D
Int J Mol Sci. 2023; 24(23).
PMID: 38069171
PMC: 10706711.
DOI: 10.3390/ijms242316851.
Rodriguez I, Saavedra E, Del Rosario H, Perdomo J, Quintana J, Prencipe F
Int J Mol Sci. 2021; 22(24).
PMID: 34948260
PMC: 8706831.
DOI: 10.3390/ijms222413462.
Tveit K, Fodstad O, JOHANNESSEN J, Olsnes S
Br J Cancer. 1980; 41(5):724-33.
PMID: 7426299
PMC: 2010317.
DOI: 10.1038/bjc.1980.134.
Morton D, Eilber F, JOSEPH W, Wood W, Trahan E, KETCHAM A
Ann Surg. 1970; 172(4):740-9.
PMID: 5272336
PMC: 1397284.
DOI: 10.1097/00000658-197010000-00018.
Fairley G
Br Med J. 1970; 4(5733):483-4.
PMID: 4921237
PMC: 1820087.
DOI: 10.1136/bmj.4.5733.483.
Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.
Lewis M, Ikonopisov R, Nairn R, Phillips T, Fairley G, Bodenham D
Br Med J. 1969; 3(5670):547-52.
PMID: 4896110
PMC: 1984348.
DOI: 10.1136/bmj.3.5670.547.
Circulating antibodies in human malignant disease.
WHITEHOUSE J
Br J Cancer Suppl. 1973; 1:170-4.
PMID: 4613372
PMC: 2149063.
Diffusion chamber culture of hamster melanoma cells in vivo. Culture characteristics in iso- and heterologous host animals.
Schieferstein G, Laerum O
Arch Dermatol Forsch. 1974; 249(2):131-40.
PMID: 4425276
DOI: 10.1007/BF00595575.
BCG immunotherapy of malignant melanoma: summary of a seven-year experience.
Morton D, Eilber F, Holmes E, Hunt J, KETCHAM A, Silverstein M
Ann Surg. 1974; 180(4):635-43.
PMID: 4412271
PMC: 1344159.
DOI: 10.1097/00000658-197410000-00029.
Human sarcomas in culture. Foci of altered cells and a common antigen; induction of foci and antigen in human fibroblast cultures by filtrates.
Giraldo G, BETH E, Hirshaut Y, Aoki T, Old L, Boyse E
J Exp Med. 1971; 133(3):454-78.
PMID: 4329447
PMC: 2138946.
DOI: 10.1084/jem.133.3.454.
Fluorescent antibody studies in malignant melanoma.
Whitehead R
Br J Cancer. 1973; 28(6):525-9.
PMID: 4205845
PMC: 2008930.
DOI: 10.1038/bjc.1973.182.
Immunological studies on malignant melanomas of man.
Romsdahl M, Cox I
Yale J Biol Med. 1973; 46(5):693-701.
PMID: 4205125
PMC: 2592017.
Studies of humoral and cell-mediated immunity in human melanoma.
Mukherji B, NATHANSON L, Clark D
Yale J Biol Med. 1973; 46(5):681-92.
PMID: 4130586
PMC: 2591996.
B cell-adherent splenocytes precede the onset of diabetes in low-dose streptozotocin-treated mice.
Feve B, Segain J, Charbonnel B, Sai P
Diabetologia. 1990; 33(1):9-14.
PMID: 2137423
DOI: 10.1007/BF00586455.
Expression of the cholecystokinin gene in pediatric tumors.
Friedman J, Vitale M, Maimon J, Israel M, Horowitz M, Schneider B
Proc Natl Acad Sci U S A. 1992; 89(13):5819-23.
PMID: 1631063
PMC: 402109.
DOI: 10.1073/pnas.89.13.5819.
Cytotoxicity of lymphocytes from healthy subjects and from melanoma patients against cultured melanoma cells.
KOURILSKY F, Picard F, BANZET P, Puissant A
Clin Exp Immunol. 1975; 21(3):430-41.
PMID: 1204255
PMC: 1538312.
Establishment of a cell line (SH-4) from pleural effusion of a patient with melanoma.
SEMAN G, Hunter S, LUKEMAN J, DMOCHOWSKI L
In Vitro. 1975; 11(4):205-11.
PMID: 1176156
DOI: 10.1007/BF02616335.
Human melanoma FUHS-1. Description of a new cell line.
MISGELD V, Meisel C
Arch Dermatol Forsch. 1975; 251(3):205-20.
PMID: 1090262
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.
Carey T, Takahashi T, Resnick L, Oettgen H, Old L
Proc Natl Acad Sci U S A. 1976; 73(9):3278-82.
PMID: 1067619
PMC: 431008.
DOI: 10.1073/pnas.73.9.3278.
Biological properties of human melanoma cells in culture.
Creasey A, Smith H, Hackett A, Fukuyama K, Epstein W, MADIN S
In Vitro. 1979; 15(5):342-50.
PMID: 478563
DOI: 10.1007/BF02616140.
